New daily pill shows promise for tough cancers
Disease control
Recruiting now
This study tests a new daily pill, ABP1011T, in people with advanced solid tumors like small cell lung cancer, esophageal cancer, and others that have stopped responding to standard treatments. About 110 participants will take one tablet each day on an empty stomach in 21-day cyc…
Phase: PHASE2 • Sponsor: Shanghai AB PharmaTech Ltd. • Aim: Disease control
Last updated May 26, 2026 08:07 UTC